Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  gastrointestinal complications
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 28 for your search:
Start Over
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065713, E-E1295, CLB-9770, SWOG-E1295, NCI-P97-0081, NCT00003057
Phase III Double Blind, Placebo Controlled Study of Sucralfate for Treatment-Induced Diarrhea in Patients Receiving Pelvic Radiation Therapy
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-949252, NCI-P97-0083
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065974, NCCTG-969256, NCI-P97-0127, NCT00003170
Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9809, CDR0000066979, RTOG-DEV-1016, NCT00003825
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069304, NCCTG-N00CA, NCI-P02-0221, N00CA, NCT00033605
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase: Phase III
Type: Supportive care, Tissue collection/Repository
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N08C9, NCI-2011-02602, CDR0000684240, N08C9, NCT01198145
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 98CC2, NCI-G00-1703, NCT00004910
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 98CC3, NCI-G00-1704, NCT00004911
Managing Medication-induced Constipation in Cancer: A Clinical Trial
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-15712, NCT01416909
Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 020215, 02-C-0215, NCI-02-C-0215, NCT00045253, NCT00040365
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: J0326, CDR0000441133, P30CA006973, JHOC-J0326, JHOC-03070804, J0326, NCT00258180
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0526, CDR0000533887, NCT00450411
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MDA-2008-0005, CDR0000612205, 2008-0005, NCT00748215
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: NU 97X1, NCI-G00-1685, NCT00004895
Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1012, CDR0000690182, NCI-2011-02620, NCT01262560
Trial of Acupuncture for Reduction of Post-Colectomy Ileus
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 06-145, NCT00402961
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RP 02-24, RPCI-RP-0224, NCT00084721
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 1 to 30 at diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000373759, P01CA081403, N2003-01, NANT-2003-01, NCT00093353
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: Under 21
Sponsor: NCI, Other
Protocol IDs: CPTCEF, NCT00143533
Study of the Efficacy of Octreotide for the Treatment of Immunotherapy-Induced Diarrhea (Summary Last Modified 01/92)
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-92-C-0040, NCI-T91-0270N, T91-0270
Study of Octreotide for Irinotecan-Induced Diarrhea in Patients With Metastatic Colorectal Cancer
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NU-00I1, NU-IRB-119-280, NOVARTIS-NU-00I1
Randomized Study of Methylnaltrexone for Opioid-Related Constipation in Patients With Incurable Cancer or Other Advanced Medical Illness
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UVACC-HIC-10593, PROGENICS-MNTX-301
Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000489157, JHOC-J05109, JHOC-NA_00001547, NCT00372450
Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 21 to 79
Sponsor: NCI, Other
Protocol IDs: H-26283, 5R01CA120950, NCT00629265
Start Over